Ernst Max writes: Over the last two weeks I have found articles in my special RSS Feed inbox these articles, which more than emphasize how nano may change the world for patients - and large drug companies. Read the following and follow the links:
Decision Resources, Inc., one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, came out with a press release today announcing that that Neurochem’s Alzhemed (tramiprosate) and Myriad Genetics’ Flurizan (R-flurbiprofen) will account for nearly 60% of the market to treat Alzheimer’s disease by 2015. Both drugs have shown promise in early clinical development, and will be the first treatments for Alzheimer’s disease that modify the course of the disease. Both agents will reach the U.S. market in 2008 and the European market by 2010. Click to read more
A powerful but cheap nanotech tool available this year could test for everything from genetic diseases to heart-attack signs.Click to read more
Gold nanoparticles, radiation combo may slow Alzheimer's
Chemists
in Chile and Spain have identified a new approach for the possible
treatment of Alzheimer's disease that they say has the potential to
destroy beta-amyloid fibrils and plaque -- hypothesized to contribute
to the mental decline of Alzheimer's patients. The researchers say the
new technique, which they call a type of "molecular surgery," could
halt or slow the disease's progress without harming healthy brain
cells. The research is scheduled for publication in the Jan. 11 issue
of the American Chemical Society's Nano Letters.
Click to read more
Researchers get closer to preventing Alzheimer’s disease
A recent study directed by Mount Sinai School of Medicine identifies a faulty molecule in the brain found in cases of mild cognitive impairment (MCI) Click to read more
Cancer-causing protein may heal damaged spinal cord and brain cells
Cancer researchers at Columbia University Medical Center have found that a protein known for driving the growth of cancer also plays a surprising role in restoring the ability of neurons to regenerate, making it an important target for addressing spinal cord damage or neurological diseases like Alzheimer’s.Click
Daniel Otzen of Danish Aalborg University has just received a large grant to find a cure for Parkinson's by identifying proteins and biochemical processes responsible for diseases such as Parkinson's Original text in Danish) Work to be made with large US pharma company. (Guess who).Click
Hi,
Very nice information about nanotechnology and its importance in so many applications.Thanks for bringing this to us...
Posted by: x-ray fluorescence | February 09, 2009 at 07:40 AM